Cytokine Responses in Renal Cell Cancer: Placebo Effect or True Biotherapy?
Author Information
Author(s): RTD Oliver
Primary Institution: School of Medicine & Dentistry, St Bartholomew's and The Royal London Hospitals
Hypothesis
Are cytokine responses in renal cell cancer the product of placebo effect of treatment or true biotherapy?
Conclusion
The study suggests that while some patients may benefit from immune manipulation, the evidence for the effectiveness of cytokine therapy remains inconclusive.
Supporting Evidence
- One patient achieved complete remission and stopped morphine within 7 days of starting treatment.
- Survival correlates with IL-1 levels induced by the cytokine soup.
- Previous trials have shown better survival rates after autologous lymphocyte therapy.
Takeaway
Some patients with kidney cancer might get better with special treatments that help their immune system, but it's hard to tell if it's the treatment or just a coincidence.
Methodology
The study compared survival rates of patients receiving different treatments for metastatic renal cell cancer.
Potential Biases
There may be a placebo effect influencing the response rates observed in the trials.
Limitations
The trial involved a predominantly poor-risk population and had a small sample size.
Participant Demographics
The study involved 63 patients receiving tamoxifen only and 65 patients receiving tamoxifen plus interleukin 2/alpha interferon.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website